Senior insider sale
TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$183.4K
2.95K shares
What this filing means
GOODRICH KATHERINE plans to sell 2.95K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $183.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/15/2026ACC: 0001959173-26-004641
Director
Since Nov 2024
2.95K
Shares to sell
$183.4K
Approx. market value
2.95K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/12/2026
2.95KTotal acquired2.95K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/12/2026 | Restricted Stock Vesting Compensation | 2.95K | — |
| Total | 2.95K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
2.95K
Market value
$183.4K
6/15/2026
Total
Units
2.95K
Value
$183.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/15/2026 | 2.95K | $183.4K | NASDAQ | Planned |
| Total | 2.95K | $183.4K | ||